T2 - Shared experiences and lessons learnt during the pandemic: Mental health challenges
Paris
Chair(s)
Prof Parisa Aslani
(Australia)
Introduction
As the pandemic continues to severely disrupt healthcare systems and economies worldwide, key stakeholders in global health — including members of the pharmacy profession — are playing a crucial role in fighting the virus. COVID-19 has posed tremendous challenges for the world and lessons to prepare the health workforce for public health crises and unexpected events/disasters. The pandemic has also uncovered the impact challenges are having on the mental health of healthcare providers. In this session, panellists will discuss these challenges, strategies related to interventions and supportive mechanisms in the area of mental health of the pharmaceutical workforce.
Programme
| 11:00 – 11:10 | Introduction by the chair | |
| 11:10 – 11:25 |
|
Mental health: the impact of COVID on our elderly populations. Opportunities for pharmacy to step up Meredith Fendt-Newlin, WHO, Switzerland |
| 11:25 – 11:40 |
|
Mental health, the impact on health professions: WHPA and the ways we can respond to our professions’ needs. Howard Catton, International Council of Nurses (member of WHPA), Switzerland |
| 11:40 – 12:20 | Q&A | |
| 12:20 – 12:30 |
|
Conclusion by the chair |
Learning Objectives
- To describe how the COVID-19 pandemic unmasked new and existing challenges in mental health among healthcare workers and frontliners including members of the pharmaceutical workforce
- To describe strategies and mechanisms implemented to address mental health issues of healthcare workers and frontliners including members of the pharmaceutical workforce from various stakeholders, professional bodies and government agencies
